Bayer Pharma AG

Bayer Pharma AG is a company in Berlin, Germany that has taken part in 31 EU-funded projects since 2009, receiving €1.3M in EU funding and leading 1 as coordinator.

EU funding received€1.3M
EU projects31
As coordinator1
Running now1
First EU project2009
Latest project2025
CountryGermany
EU registration (PIC)997912333
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Bayer Pharma AG's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€988k · 21 projects
  • Horizon 2020€353k · 9 projects
  • Horizon Europe€0 · 1 project

Projects

31 EU-funded projects, newest first. Bayer Pharma AG led 1 of them as coordinator. Each links to the official record.

  • BRIDGE-AIAssociated partner

    BRaIn Disease monitoring throuGh the lifE span powered by Artificial Intelligence

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • CaReSyAnPartner

    Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

  • HARMONYPartner

    Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

  • IB4SD-TRISTANPartner

    Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

    Horizon 2020 · 2017–2024 · Project on CORDIS ↗

  • PREFERPartner

    Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

  • BEAt-DKDPartner

    Biomarker Enterprise to Attack DKD - Sofia ref.: 115974

    Horizon 2020 · 2016–2023 · Project on CORDIS ↗

  • ENLIGHT-TENPartner

    European Network linking informatics and genomics of helper T cells

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €104ktheir share
  • ADAPT-SMARTPartner

    Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • IDEASPartner

    Improving Design, Evaluation and Analysis of early drug development Studies

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €249ktheir share
  • MAGICBULLETPartner

    Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • WEB-RADRPartner

    Recognising Adverse Drug Reactions

    FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗

  • CanDoPartner

    A CANcer Development mOnitor

    FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗

    €254ktheir share
  • GETREALPartner

    Incorporating real-life clinical data into drug development

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  • RADOXPartner

    RADical reduction of OXidative stress in cardiovascular diseases

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €95ktheir share
  • CHEM21Partner

    Chemical Manufacturing Methods for the 21st Century Pharmaceutical Industries

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

  • ABIRISKPartner

    Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

  • EUPATIPartner

    European Patients' Academy on Therapeutic Innovation

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

  • IONTRACPartner

    Ion Transport Proteins in Control of Cancer Cell Behaviour

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €234ktheir share
  • EHR4CRPartner

    Electronic Health Record systems for Clinical Research

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

  • PREDECTPartner

    New Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

  • EPC-TM-NETPartner

    Targeting the tumour microenvironment to improve pancreatic cancer prognosis

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €76ktheir share
  • ONCOTRACKCoordinator

    OncoTrack - Methods for systematic next generation oncology biomarker development

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

  • PREDICTPartner

    Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €329ktheir share
  • MARCARPartner

    bioMARkers and molecular tumor classification for non-genotoxic CARcinogenesis

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

  • ETOXPartner

    Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities

    FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗

  • SAFESCIMETPartner

    European Modular Education and Training Programme in Safety Sciences for Medicines

    FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗

  • EMTRAINPartner

    European Medicines Research Training Network

    FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗

  • PROTECTPartner

    Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium

    FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗

  • EU2PPartner

    European programme in Pharmacovigilance and Pharmacoepidemiology

    FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗

  • SAFE-TPartner

    SAFER AND FASTER EVIDENCE-BASED TRANSLATION

    FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗

  • PHARMATRAINPartner

    Pharmaceutical Medicine Training Programme

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • adverse drug reactions
  • angiology
  • artificial intelligence
  • autoimmune diseases
  • big data
  • biocatalysis
  • bioreactors
  • business models
  • cardiovascular diseases
  • cell biology
  • colorectal cancer
  • data mining

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime